| Good Samaritan Hospice Of Madison 540 Hughes Road, Suite 12, Madison, AL, 35758 | |
| (256) 772-8108 |
News Archive
New research is helping unlock the mystery of how the brain folds as a baby develops in the womb - a process critical to healthy brain function.
Genetic mutations in the Toll-like receptor 4 (TLR4) gene appear to have significant association with inflammatory injury to the placenta and developing baby, researchers from the University of Pittsburgh's department of obstetrics, gynecology and reproductive sciences report at the 28th annual meeting of the Society for Maternal-Fetal Medicine.
Denmark-based LEO Pharma, a global leader in dermatology and critical care, announced its official launch in the U.S. Headquartered in Parsippany, New Jersey, LEO Pharma U.S. will be one of the largest individual operations in the pharmaceutical company's network of worldwide affiliates and is expected to contribute significantly to the company revenues in 2010.
Small non-coding RNAs can be used to predict if individuals have breast cancer conclude researchers who contribute to The Cancer Genome Atlas project. The results, which are published in EMBO reports, indicate that differences in the levels of specific types of non-coding RNAs can be used to distinguish between cancerous and non-cancerous tissues. These RNAs can also be used to classify cancer patients into subgroups of individuals that have different survival outcomes.
› Verified 9 days ago
| Name | Good Samaritan Hospice Of Madison |
|---|---|
| Location | 540 Hughes Road, Suite 12, Madison, Alabama |
| Hospice ID | 011676 |
| Category | Freestanding Hospice |
| Ownership Type | Other |
| Profit Type | OTHER |
| SSA county code | 440 |
News Archive
New research is helping unlock the mystery of how the brain folds as a baby develops in the womb - a process critical to healthy brain function.
Genetic mutations in the Toll-like receptor 4 (TLR4) gene appear to have significant association with inflammatory injury to the placenta and developing baby, researchers from the University of Pittsburgh's department of obstetrics, gynecology and reproductive sciences report at the 28th annual meeting of the Society for Maternal-Fetal Medicine.
Denmark-based LEO Pharma, a global leader in dermatology and critical care, announced its official launch in the U.S. Headquartered in Parsippany, New Jersey, LEO Pharma U.S. will be one of the largest individual operations in the pharmaceutical company's network of worldwide affiliates and is expected to contribute significantly to the company revenues in 2010.
Small non-coding RNAs can be used to predict if individuals have breast cancer conclude researchers who contribute to The Cancer Genome Atlas project. The results, which are published in EMBO reports, indicate that differences in the levels of specific types of non-coding RNAs can be used to distinguish between cancerous and non-cancerous tissues. These RNAs can also be used to classify cancer patients into subgroups of individuals that have different survival outcomes.
› Verified 9 days ago
| NPI Number | 1396767224 |
| Organization Name | Good Samaritan Hospice Usa Inc |
| Address | 402 E Dr Hicks Blvd Florence, Alabama, 35630 |
| Phone Number | (256)767-4799 |
News Archive
New research is helping unlock the mystery of how the brain folds as a baby develops in the womb - a process critical to healthy brain function.
Genetic mutations in the Toll-like receptor 4 (TLR4) gene appear to have significant association with inflammatory injury to the placenta and developing baby, researchers from the University of Pittsburgh's department of obstetrics, gynecology and reproductive sciences report at the 28th annual meeting of the Society for Maternal-Fetal Medicine.
Denmark-based LEO Pharma, a global leader in dermatology and critical care, announced its official launch in the U.S. Headquartered in Parsippany, New Jersey, LEO Pharma U.S. will be one of the largest individual operations in the pharmaceutical company's network of worldwide affiliates and is expected to contribute significantly to the company revenues in 2010.
Small non-coding RNAs can be used to predict if individuals have breast cancer conclude researchers who contribute to The Cancer Genome Atlas project. The results, which are published in EMBO reports, indicate that differences in the levels of specific types of non-coding RNAs can be used to distinguish between cancerous and non-cancerous tissues. These RNAs can also be used to classify cancer patients into subgroups of individuals that have different survival outcomes.
› Verified 9 days ago
| NPI Number | 1639202435 |
| Organization Name | Good Samaritan Hospice Of Madison Inc. |
| Address | 540 Hughes Rd Madison, Alabama, 35758 |
| Phone Number | (256)767-4799 |
News Archive
New research is helping unlock the mystery of how the brain folds as a baby develops in the womb - a process critical to healthy brain function.
Genetic mutations in the Toll-like receptor 4 (TLR4) gene appear to have significant association with inflammatory injury to the placenta and developing baby, researchers from the University of Pittsburgh's department of obstetrics, gynecology and reproductive sciences report at the 28th annual meeting of the Society for Maternal-Fetal Medicine.
Denmark-based LEO Pharma, a global leader in dermatology and critical care, announced its official launch in the U.S. Headquartered in Parsippany, New Jersey, LEO Pharma U.S. will be one of the largest individual operations in the pharmaceutical company's network of worldwide affiliates and is expected to contribute significantly to the company revenues in 2010.
Small non-coding RNAs can be used to predict if individuals have breast cancer conclude researchers who contribute to The Cancer Genome Atlas project. The results, which are published in EMBO reports, indicate that differences in the levels of specific types of non-coding RNAs can be used to distinguish between cancerous and non-cancerous tissues. These RNAs can also be used to classify cancer patients into subgroups of individuals that have different survival outcomes.
› Verified 9 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 100.0 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 99.3 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 67.9 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 100.0 | 97.3 |
| Patients who got timely treatment for shortness of breath | 100.0 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 97.4 | 93.3 |
News Archive
New research is helping unlock the mystery of how the brain folds as a baby develops in the womb - a process critical to healthy brain function.
Genetic mutations in the Toll-like receptor 4 (TLR4) gene appear to have significant association with inflammatory injury to the placenta and developing baby, researchers from the University of Pittsburgh's department of obstetrics, gynecology and reproductive sciences report at the 28th annual meeting of the Society for Maternal-Fetal Medicine.
Denmark-based LEO Pharma, a global leader in dermatology and critical care, announced its official launch in the U.S. Headquartered in Parsippany, New Jersey, LEO Pharma U.S. will be one of the largest individual operations in the pharmaceutical company's network of worldwide affiliates and is expected to contribute significantly to the company revenues in 2010.
Small non-coding RNAs can be used to predict if individuals have breast cancer conclude researchers who contribute to The Cancer Genome Atlas project. The results, which are published in EMBO reports, indicate that differences in the levels of specific types of non-coding RNAs can be used to distinguish between cancerous and non-cancerous tissues. These RNAs can also be used to classify cancer patients into subgroups of individuals that have different survival outcomes.
› Verified 9 days ago
| Home Health Aides | 6 |
| Counselors | 1.5 |
| Homemakers | 0.5 |
| Medical Social Workers | 3 |
| Physicians | 3 |
| Registered Nurses | 8 |
| Other Personnel | 5 |
| Total Employees | 27 |
|---|
News Archive
New research is helping unlock the mystery of how the brain folds as a baby develops in the womb - a process critical to healthy brain function.
Genetic mutations in the Toll-like receptor 4 (TLR4) gene appear to have significant association with inflammatory injury to the placenta and developing baby, researchers from the University of Pittsburgh's department of obstetrics, gynecology and reproductive sciences report at the 28th annual meeting of the Society for Maternal-Fetal Medicine.
Denmark-based LEO Pharma, a global leader in dermatology and critical care, announced its official launch in the U.S. Headquartered in Parsippany, New Jersey, LEO Pharma U.S. will be one of the largest individual operations in the pharmaceutical company's network of worldwide affiliates and is expected to contribute significantly to the company revenues in 2010.
Small non-coding RNAs can be used to predict if individuals have breast cancer conclude researchers who contribute to The Cancer Genome Atlas project. The results, which are published in EMBO reports, indicate that differences in the levels of specific types of non-coding RNAs can be used to distinguish between cancerous and non-cancerous tissues. These RNAs can also be used to classify cancer patients into subgroups of individuals that have different survival outcomes.
› Verified 9 days ago
| Others | 5 |
| Total Volunteers | 5 |
|---|
News Archive
New research is helping unlock the mystery of how the brain folds as a baby develops in the womb - a process critical to healthy brain function.
Genetic mutations in the Toll-like receptor 4 (TLR4) gene appear to have significant association with inflammatory injury to the placenta and developing baby, researchers from the University of Pittsburgh's department of obstetrics, gynecology and reproductive sciences report at the 28th annual meeting of the Society for Maternal-Fetal Medicine.
Denmark-based LEO Pharma, a global leader in dermatology and critical care, announced its official launch in the U.S. Headquartered in Parsippany, New Jersey, LEO Pharma U.S. will be one of the largest individual operations in the pharmaceutical company's network of worldwide affiliates and is expected to contribute significantly to the company revenues in 2010.
Small non-coding RNAs can be used to predict if individuals have breast cancer conclude researchers who contribute to The Cancer Genome Atlas project. The results, which are published in EMBO reports, indicate that differences in the levels of specific types of non-coding RNAs can be used to distinguish between cancerous and non-cancerous tissues. These RNAs can also be used to classify cancer patients into subgroups of individuals that have different survival outcomes.
› Verified 9 days ago
| Good Samaritan Hospice Of Madison Location: 540 Hughes Road, Suite 12, Madison, Alabama, 35758 Phone: (256) 772-8108 |